A peroxisome proliferator-activated receptor-alpha (PPARα) cDNA cloned from guinea-pig liver encodes a protein wit h similar properties to the mouse PPARα: Implications for species differences in responses to peroxisome proliferators

Archives of Toxicology

Volumn 72, Issue 3, 1998, Pages 169-177

  Tugwood, Jonathan D ^a   Holden, Peter R ^a   James, Neil H ^a   Prince, Rebecca A ^a   Roberts, Ruth A ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

Activated receptor; Apoptosis; Peroxisome proliferator; Species differences; Transcriptional activation

Indexed keywords

MESSENGER RNA; NAFENOPIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PIRINIXIC ACID; RETINOID X RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA BINDING; GENE ACTIVATION; GENE EXPRESSION; GUINEA PIG; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIVER; LIVER CELL CULTURE; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; RNA HYBRIDIZATION; SEQUENCE HOMOLOGY; SPECIES DIFFERENCE;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; GUINEA PIGS; HUMANS; LIVER; MICE; MOLECULAR SEQUENCE DATA; RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SEQUENCE HOMOLOGY, AMINO ACID; SPECIES SPECIFICITY; TRANSCRIPTION FACTORS;

EID: 0031915653     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002040050483     Document Type: Article

References (51)

1. Aldridge TC, Tugwood JD, Green S (1995) Identification and characterisation of DNA elements implicated in the regulation of CYP4A1 transcription. Biochem J 306: 473-479
2. Ashby J, Brady A, Elcombe CR, Elliott BM, Ishmael J, Odum J, Tugwood JD, Kettle S, Purchase IFH (1994) Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis. Hum Exp Toxicol 13: S1-S117
3. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (1995) Current protocols in molecular biology. Wiley, New York
4. Barber ED, Astill BD, Moran EJ, Schneider BF, Gray TJB, Lake BG, Evans JG (1987) Peroxisome induction studies on seven phthalate esters. Toxicol Ind Health 3: 130
5. Bayly AC, Roberts RA, Dive C (1994) Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator, nafenopin. J Cell Biol 125: 197-203
6. Blaauboer BJ, van Holstein CW, Bleumink R, Menues WC, van Peu FN, Yap SH, van Pelt JF, van Iersel AA, Timmerman A, Schmidt BP (1990) The effects of beclobric acid and clofibric acid on peroxisomal β-oxidation and peroxisome proliferation in primary cultures of rat, monkey and human hepatocytes. Biochem Pharmacol 40: 521-528
7. Bojes HK, Germolec DR, Simeonova P, Bruccoleri A, Schoonhoven R, Luster MI, Thurman RG (1997) Antibodies to tumour necrosis factor alpha prevent increases in cell replication in liver due to the potent peroxisome proliferator, WY-14,643. Carcinogenesis 18: 669-674
8. Bourguet W, Ruff M, Chambon P, Gronemeyer H, Moras D (1995) Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature 375: 377-382
9. Cary NC (1989) SAS STAT User's Guide. SAS Institute Incorporated
10. Chinje F, Kentish P, Jarnot B, George M, Gibson G (1994) Induction of the CYP4A subfamily by perfluorodecanoic acid: the rat and the guinea-pig as susceptible and non-susceptible species. Toxicol Lett 71: 69-75
11. Devchand PR, Keller H, Peters JM, Vazquez M, Gonzalez FJ, Wahli W (1996) The PPARα-leukotriene B4 pathway to inflammation control. Nature 384: 39-43
12. Dirvan HA, van den Brock PH, Peeters MC, Peters JG, Mennes WC, Blaauboer BJ, Noordhoek J, Jongeneelen FJ (1993) Effects of the peroxisome proliferator mono(2-ethylhexyl)phthalate in primary hepatocyte cultures derived from rat, guinea-pig, rabbit, and monkey. Relationship between interspecies differences in biotransformation and peroxisome proliferating potencies. Biochem Pharmacol 45: 2425-2434
13. Dowell P, Peterson VJ, Zabriskie TM, Leid M (1997) Ligand-induced peroxisome proliferator-activated receptor alpha conformational change. J Biol Chem 272: 2013-2020
14. Dreyer C, Krey G, Keller H, Givel F, Helftenbein G, Wahli W (1992) Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68: 879-887
15. Dugaiczyk A, Law SW, Dennison OE (1982) Nucleotide sequence and the encoded amino acids of human serum albumin mRNA. Proc Natl Acad Sci USA 79: 71-75
16. Durand B, Saunders M, Gaudon C, Roy B, Losson R, Chambon P (1994) Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity. EMBO J 13: 5370-5382
17. Elcombe CR (1985) Species differences in carcinogenicity and peroxisome proliferation due to trichloroethylene: a biochemical human hazard assessment. Arch Toxicol Suppl 8: 6-17
18. Fawell SE, Lees JA, White R, Parker MG (1990) Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor. Cell 60: 953-962
19. Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V, et al (1987) Helsinki heart study: primary-prevention trial with gemfibrozil in middle-aged men with dislipidemia. New Engl J Med 317: 1235-1247
20. Göttlicher M, Widmark E, Li Q, Gustafsson J-A (1992) Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc Natl Acad Sci USA 89: 4653-4657
21. Issemann I, Green S (1990) Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347: 645-649
22. Issemann I, Prince RA, Tugwood JD, Green S (1993a) The PPAR:RXR heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. J Mol Endocrinol 11: 37-47
23. Issemann I, Prince RA, Tugwood JD, Green S (1993b) The retinoid X receptor enhances the function of the peroxisome proliferator activated receptor. Biochimie 75: 251-256
24. James NH, Roberts RA (1996) Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis. Carcinogenesis 17: 1623-1632
25. Kliewer SA, Umesono K, Noonan DJ, Heyman RA, Evans RM (1992) Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358: 771-774
26. Kliewer SA, Forman BM, Blumberg B, Ong ES, Borgmeyer U, Mangelsdorf DJ, Umesono K, Evans RM (1994) Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA 91: 7355-7359
27. Lake BG, Evans JG, Gray TJB, Körösi SA, North CJ (1989) Comparative studies on nafenopin-induced hepatic peroxisome proliferation in the rat, Syrian hamster, guinea-pig, and marmoset. Toxicol Appl Pharmacol 99: 148-160
28. Lake BG, Evans JG, Cunninghame ME, Price RJ (1993) Comparison of the hepatic effects of nafenopin and Wy-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster. Environ Health Perspect 101 (Suppl 5): 241-247
29. Lambe KG, Tugwood JD (1996) A human peroxisome-proliferator-activated receptor-gamma is activated by inducers of adipogenesis, including thiazolidinedione drugs. Eur J Biochem 239: 1-7
30. Lee SST, Pineau T, Drago J, Lee EJ, Owens JW, Kroetz DL, Fernandez-Salguero PM, Westphal H, Gonzalez FJ (1995) Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 15: 3012-3022
31. Makowska JM, Gibson GG, Bonner FW (1992) Species differences in ciprofibrate induction of hepatic cytochrome P450 4A1 and peroxisome proliferation. J Biochem Toxicol 7: 183-191
32. Pacot C, Petit M, Rollin M, Behechti N, Moisant M, Deslex P, Althoff J, Lhuguenot JC, Latruffe N (1996) Difference between guinea-pig and rat in the liver peroxisomal response to equivalent plasmatic level of ciprofibrate. Arch Biochem Biophys 327: 181-188
33. Rao MS, Subbarao V (1997) Effect of dexamethasone on ciprofibrate-induced cell proliferation and peroxisome proliferation. Fundam Appl Toxicol 35: 78-83
34. Reddy JK, Lalwani ND (1983) Carcinogenesis by hepatic peroxisome proliferators. Evaluation of the risk of hepatocarcinogenic drugs and industrial plasticizers to humans. Crit Rev Toxicol 12: 1-58
35. Reddy JK, Azarnoff DL, Hignite CE (1980) Hypolipidemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature 283: 397-398
36. Rich BE, Steitz JA (1987) Human acidic ribosomal phosphoproteins P0, P1 and P2: analysis of cDNA clones, in vitro synthesis, and assembly. Mol Cell Biol 7: 4065-4074
37. Roberts RA, Jones NH, Woodyatt NJ, Mcdonald N, Tugwood JD (1997) Evidence for the suppression of apoptosis by PPARα. Carcinogenesis 19: (in press)
38. Rokos CL, Ledwith BJ (1997) Peroxisome proliferators activate extracellular signal-regulated kinases in immortalized mouse liver cells. J Biol Chem 272: 13452-13457
39. Rolfe M, James NH, Roberts RA (1997) Tumour necrosis factor α (TNFα) suppresses apoptosis and induces DNA synthesis in rodent hepatocytes: a mediator of the hepatocarcinogenicity of peroxisome proliferators? Carcinogenesis 18: 2277-2280
40. Salbert G, Fanjui A, Piedrafita FJ, Lu XP, Kim S-J, Tran P, Pfahl M (1993) Retinoic acid receptors and retinoid X receptor-alpha down-regulate the Transforming Growth Factor-β1 promoter by antagonizing AP-1 activity. Mol Endocrinol 7: 1347-1356
41. Schoonjans K, Staels B, Auwerx J (1996) Role of the peroxisome proliferator activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 37: 905-925
42. Seglen PO (1973) Preparation of rat liver cells. III. Enzymatic requirements for tissue dispersion. Exp Cell Res 82: 391-398
43. Shepherd J (1995) Fibrates and statins in the treatment of hyperlipidaemia: an appraisal of their efficacy and safety. Eur Heart J 16: 5-13
44. Sher T, Yi H-F, McBride OW, Gonzalez FJ (1993) cDNA cloning, chromosomal mapping, and functional characterisation of the human peroxisome proliferator activated receptor. Biochemistry 32: 5598-5604
45. Strange J, Roberts RA (1996) Reduced expression of mature TGFβ1 correlates with the suppression of rat hepatocyte apoptosis by the peroxisome proliferator, nafenopin. Mutat Res 372: 107-113
46. Stringer DA (1992) ECETOC Monograph no.17 Hepatic peroxisome proliferation. Brussels, Belgium
47. Styles JA, Kelly M, Pritchard NR, Elcombe CR (1988) A species comparison of acute hyperplasia induced by the peroxisome proliferator methylclofenapate: involvement of the binucleated hepatocyte. Carcinogenesis 9: 1647-1655
48. Tugwood JD, Issemann I, Anderson RG, Bundell KR, McPheat WL, Green S (1992) The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking region of the rat acyl CoA oxidase gene. EMBO J 11: 433-439
49. Tugwood JD, Aldridge TC, Lambe KG, Macdonald N, Woodyatt NJ (1996) Peroxisome proliferator-activated receptors: structures and function. Ann NY Acad Sci 804, New York. pp. 252-265
50. Wada N, Marsman DS, Popp JA (1992) Dose-related effects of the hepatocarcinogen, Wy-14,643, on peroxisomes and cell replication. Fundam Appl Toxicol 18: 149-154
51. Zhang B, Marcus SL, Fereydoun GS, Alvares K, Reddy JK, Subramani S, Rachubinski RA, Capone JP (1992) Identification of a peroxisome proliferator responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase 3-hydroxyacyl-CoA dehydrogenase. Proc Natl Acad Sci USA 89: 7541-7545